20th February 2025

Management of HP

Antigen exposure avoidance is key. Supportive therapies include oxygen and bronchodilators.

Corticosteroids may be useful to alleviate symptoms but do not have an effect on the long-term outcome of the condition.

Lung transplantation may be considered, although if re-exposure occurs, the patient may develop severe damage to the transplanted lung. 

See note on nintedanib – this has now been approved as a treatment option for chronic progressive fibrosing interstitial lung diseases.